ALIM Alimera Sciences Inc

Alimera Sciences Inc is a biopharmaceutical company which is engaged in the research, development, and commercialization of ophthalmic pharmaceuticals.

$9.67
As of 05/07/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  04/22/2010
Outstanding shares:  6,898,437
Average volume:  61,496
Market cap:   $64,431,402
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    016259202
ISIN:        US0162592028
Sedol:      BK72RN0
Valuation   (See tab for details)
PE ratio:   -8.56
PB ratio:   -20.19
PS ratio:   1.36
Return on equity:   65.13%
Net income %:   -16.40%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy